China NMPA has granted acceptance and priority review for the NDA for HUTCHMED’s...
Innovent and Roche have entered a partnership and exclusive licence agreement to...
Sangamo said it plans to explore all options to commercialise the asset, includi...
Tevimbra is under clinical development by BeiGene and currently in Phase II for ...
Tevimbra is under clinical development by BeiGene and currently in Phase II for ...
Iptacopan hydrochloride is under clinical development by Novartis and currently ...
CT-7439 is under clinical development by Carrick Therapeutics and currently in P...
ITM-91 is under clinical development by ITM Isotope Technologies Munich and curr...
ITM-91 is under clinical development by ITM Isotope Technologies Munich and curr...
Tebapivat is under clinical development by Agios Pharmaceuticals and currently i...
LXE-408 is under clinical development by Novartis and currently in Phase I for C...
Xaluritamig is under clinical development by Amgen and currently in Phase I for ...
NVP-1805R2 is under clinical development by NVP Healthcare and currently in Phas...
Tricaprilin is under clinical development by Cerecin and currently in Phase II f...
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol...
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol...
